Tryptyr Logo

 

 

 

When treating the signs and symptoms
of dry eye disease, TRYPTYR delivers

 

RAPID

NATURAL TEAR PRODUCTION

AS EARLY AS DAY 11

 

 

When treating the signs and symptoms of dry eye disease, TRYPTYR delivers

 

RAPID

NATURAL TEAR PRODUCTION

AS EARLY AS DAY 11

NEW TRYPTYR: a first-in-class neuromodulator eye drop that rapidly increases natural tear production as early as Day 11-5

NEW TRYPTYR: a first-in-class neuromodulator eye drop that rapidly increases natural tear production as early as Day 11-5

 
 
Alt text
Alt text
Rapid results

 

Alt text
Alt text
Symptom relief

 

Alt text
Alt text
First-in-class MOA

 

 

Simple dosing with TRYPTYR1

 

Alt text

TRYPTYR works differently1-5

 

See how TRYPTYR rapidly increases tear production by stimulating corneal sensory nerves1

TRYPTYR works differently1-5

 

See how TRYPTYR rapidly increases tear production by stimulating corneal sensory nerves1

Help your patients benefit from rapid natural tear production

Help your patients benefit from rapid natural tear production

  

REFERENCES

 

  1. TRYPTYR. Prescribing Information. Alcon, Inc., 2025.
  2. Restasis. Prescribing Information. AbbVie; 2024.
  3. Xiidra. Prescribing Information. Bausch & Lomb; 2023.
  4. Tyrvaya. Prescribing Information. Oyster Point Pharma, Inc., 2024.
  5. Miebo. Prescribing Information. Bausch & Lomb; 2023.

     

IMPORTANT SAFETY INFORMATION

Warnings and Precautions

Potential for Eye Injury and Contamination: To avoid the potential for eye injury and contamination, advise patients not to touch the vial tip to the eye or other surfaces.

INDICATIONS AND USAGE

TRYPTYR (acoltremon ophthalmic solution) 0.003% is indicated for the treatment of the signs and symptoms of dry eye disease (DED).

Use with Contact Lenses: TRYPTYR should not be administered while wearing contact lenses. If contact lenses are worn, they should be removed prior to administration of the solution. Lenses may be reinserted 15 minutes following administration.

 

Adverse Reactions 

In clinical trials, the most common adverse reaction was instillation site pain (50%).

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

 

Please click here for the TRYPTYR Full Prescribing Information.